P155 Transdermal oestrogen prevents cyclically-recurrent genital herpes: Abstract P155 Table 1

Clinical significance of p155 antibody in dermatomyositis

Introduction Dermatomyositis is associated with an increased risk of malignancy, however, universal screening guidelines are not established. Recently the p155 antibody has been reported, along with an association with malignancy in dermatomyositis. The aim of this paper is to review the literature on the p155 antibody in DM and explore the implications this new marker may have in the clinical ...

Treatment of recurrent genital Herpes with Imiquimod: A case report

In this report, a 32 year-old patient is reported who was suffering from recurrent genital herpes for 3 years and her disease could not be controlled with conventional treatment methods. But, application of Imiquimod 5% cream, 3 times a week for 3 months, proved very effective with no recurrence for up to 7 months. Since recurrent genital herpes is the result of some immunologic dysfunctions ca...

When recurrent genital sores are not genital herpes.

Case report A 32 year old married woman attended the genitourinary medicine clinic at Hertford County Hospital, requesting investigation for genital herpes. She previously had a normal delivery with an episiotomy in 1984. She complained of soreness in the vagina lasting 4–5 days every month for 3 years, ever since she had a total hysterectomy in March 1994. The symptoms usually started about th...

Short-course therapy for recurrent genital herpes and herpes labialis.

P155: Differential Diagnosis of Panic Attacks: Using a Decision Tree

Panic attacks are discrete episodes of intense fear or discomfort accompanied by symptoms such as palpitations, shortness of breath, sweating, trembling, derealization and a fear of losing control or dying. Although panic attacks are required for a diagnosis of panic disorder, they also occur in association with a host of other disorders listed in the 5h version of the diagnostic and statistica...